Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unusual hypokalaemia

P L Selvais1, L de Cannière, L Michel

  • 1Service de Médecine Interne Générale et Endocrinologie, Université Catholique de Louvain, Cliniques Universitaires de Mont-Godinne, Y voir, Belgique.

Acta Clinica Belgica
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell therapy in multiple sclerosis: An overview.

Revue neurologique·2026
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

Monitoring polycyclic aromatic hydrocarbons deposition in eastern Canada using moss biomonitoring: A large-scale study of spatial patterns and environmental influences.

The Science of the total environment·2026
Same author

The sensory shark: high-quality morphological, genomic and transcriptomic data for the small-spotted catshark <i>Scyliorhinus canicula</i> reveal the molecular bases of sensory organ evolution in jawed vertebrates.

bioRxiv : the preprint server for biology·2024
Same author

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient.

Revue neurologique·2024
Same author

Computing Geographical Networks Generated by Air-Mass Movement.

GeoHealth·2023
Same journal

MEFV variants as phenotypic modifiers in ankylosing spondylitis: a genetic interaction analysis with HLA-B27.

Acta clinica Belgica·2026
Same journal

What Europe should (not) learn from the new Dietary Guidelines for Americans.

Acta clinica Belgica·2026
Same journal

Real-world evidence on In-hospital statin use and mortality in geriatric patients.

Acta clinica Belgica·2026
Same journal

TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

Acta clinica Belgica·2026
Same journal

A decade of insulin pump therapy in a Belgian paediatric diabetes centre: longitudinal outcomes and evolving practices.

Acta clinica Belgica·2026
Same journal

Pneumococcal vaccination in Belgian adults: a practical translation of the 2025 Superior Health Council guidelines.

Acta clinica Belgica·2026
See all related articles

Amikacin, an antibiotic, can cause severe hypokalaemia (low potassium) in patients with kidney issues. This case highlights the importance of monitoring potassium levels during amikacin treatment, especially in patients with hypernephroma or adrenal adenoma.

Area of Science:

  • Nephrology
  • Pharmacology
  • Endocrinology

Background:

  • A 72-year-old male patient with hypernephroma and an asymptomatic adrenal adenoma underwent treatment for colonic perforation.
  • The patient developed severe hypokalaemia during treatment.

Observation:

  • Amikacin, an aminoglycoside antibiotic, was administered for the colonic perforation.
  • The patient's hypokalaemia was suspected to be induced by amikacin, specifically hyperkaliuric hypokalaemia.

Findings:

  • Discontinuation of amikacin led to the resolution of hypokalaemia.
  • A review of the patient's medical history revealed a similar, previously unnoticed episode.

Implications:

  • This case underscores the potential nephrotoxic and electrolyte-disrupting effects of amikacin.

Related Experiment Videos

  • Close monitoring of serum potassium levels is crucial in patients with pre-existing renal or adrenal conditions receiving amikacin.
  • Awareness of amikacin-induced hyperkaliuric hypokalaemia is important for clinicians managing patients with complex medical histories.